Ispecimen Inc. · NASDAQ:ISPC
Ispecimen — Investor Presentation (August 2024)
28 slides from Ispecimen's investor presentation, August 2024
Slide 1: The Online Marketplace for Human Biospecimens
The Online Marketplace for Human Biospecimens Transforming Biospecimen Procurement August 2024 Investor Presentation Nasdaq: ISPC
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are characterized by future or conditio
Slide 3: Our Vision
Our Vision To support the biospecimen industry with an online marketplace connecting researchers to patients, biospecimens, and data, through our global network. 3
Slide 4: Investor Highlights
Investor Highlights 1. Similar to Amazon, iSpecimen has developed an >105 online marketplace to seamlessly connect Healthcare Provider / Supplier researchers with healthcare providers and supplier Organizations organizations 2. First mover advantage that addresses an inefficient and fragmented globa
Slide 5: Biospecimens are Essential for Life Science R&D
Biospecimens are Essential for Life Science R&D SUPPLY SIDE DEMAND SIDE HEALTHCARE PROVIDERS LIFE SCIENCE RESEARCHERS Patients Biospecimens Data Organizations Applications Biofluids Plasma, Serum, Urine, Saliva Industry Basic Research Medical Record Biomarker Identification & Solid Tissue Lung, Brea
Slide 6: Biospecimen Supply Chain Challenges
Biospecimen Supply Chain Challenges Providers miss revenue and Researchers limit research opportunities their work > 1 Billion 10 years ago, 81% Patient encounters yearly in the U.S. where a of researchers said they limit the scope of their work specimen could be provided for research 3 due to diffi
Slide 7: Biospecimen Supply Chain Challenges
Biospecimen Supply Chain Challenges -Difficult to Connect, Search and Compliantly Transact -Average time to develop relationships is 6-12 months ᶟ PROVIDERS CHALLENGE RESEARCHERS 7
Slide 8: iSpecimen Marketplace | Approach
iSpecimen Marketplace | Approach Supply Side Demand Side Providers Life Science Researchers
Slide 9: iSpecimen Value Proposition
iSpecimen Value Proposition Providers… Researchers… Monetize Banked Biospecimens Save Time and Money Instantly connect to a global network of Instantly connect to global network of researchers in search for biospecimens specimen providers Advance Scientific Discovery Accelerate Research Support rese
Slide 10: Comprehensive Supplier & Researcher Networks
Comprehensive Supplier & Researcher Networks Agreements with 140+ Supplier Organizations Global Footprint ✔ Hospitals United States Mexico ✔ Clinics and Practice Groups United Kingdom Netherlands ✔ Clinical Research Centers Germany Turkey Cyprus Romania ✔ Clinical and Pathology Labs Ukraine Armenia
Slide 11: Strategic Growth Initiatives
Strategic Growth Initiatives 11
Slide 12: Capitalize on Growing Data Asset
Capitalize on Growing Data Asset 80M+ Clinical Specimen Records 1.2M Banked Specimen Millions of Unique Specimen and + Records Patient Records provide a competitive advantage and “Utilization of sample data 15M+ Patient differentiator now and for research and for Records available for future adjacen
Slide 13: Financial Overview
> . * q ; . al P aay s - 7 i Financial Overview 13
Slide 14: Annual Revenue
Annual Revenue Annual Revenue ($1,000) $11,135 $10,402 2015 – Q2 2024 $9,928 $8,184 ▲ 39% CAGR Revenue (2015 – 2023) $5,154 $4,395 $4,298 $3,067 $1,448 $700 2015 2016 2017 2018 2019 2020 2021 2022 2023 1H24 14
Slide 15: Statement of Operations
Statement of Operations iSpecimen Inc. Condensed Statement of Operations Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 (unaudited) (unaudited) (unaudited) (unaudited) Revenue $2,863,679 $1,625,140 $5,153,672 $4,575,339 Operating expenses: Cost of revenue 1,424,392 853,633
Slide 16: Balance Sheet
Balance Sheet iSpecimen Inc. Condensed Balance Sheet Information June 30, 2024 December 31, 2023 ASSETS Cash $2,151,243 $2,343,666 Investments-short term 0 2,661,932 Accounts receivable - unbilled 1,953,632 2,212,538 Accounts receivable, net of allowance for doubtful accounts 892,814 728,388 Prepaid
Slide 17: Common Stock Information
Common Stock Information iSpecimen Inc. Fully Diluted Shares Outstanding Diluted Shares of Common Stock Shares outstanding at June 30, 2024 13,095,770 Shares issuable upon vesting of RSUs 56,558 Shares issuable upon exercise of stock options 351,670 Shares issuable upon exercise of warrant to purcha
Slide 18: Management Team
9 “Sources Cited” page 31 Management Team Tracy Curley | Chief Executive Officer, Chief Financial Officer and Treasurer Ms. Curley brings three decades of experience in public accounting and corporate finance for both publicly traded companies and emerging companies like iSpecimen and joined iSpecim
Slide 19: Investor Highlights
Investor Highlights 1. Similar to Amazon, iSpecimen has developed >105 an online marketplace to seamlessly connect Healthcare Provider / Supplier researchers with healthcare providers and Organizations supplier organizations 2. First mover advantage that addresses an inefficient and fragmented globa
Slide 20: Be a part of the biospecimen revolution
Be a part of the biospecimen revolution Contact us. iSpecimen Inc. 450 Bedford Street Lexington, MA 02420 investors@ispecimen.com Sign up for a free iSpecimen Marketplace account at iSpecimen.com
Slide 21: Appendix
Appendix 21
Slide 22: Strategic Evolution
Strategic Evolution START UP PHASE 1 PHASE 2 PHASE 3 Company Ideation and Self- Proof of Concept Critical Mass of Suppliers and Expansion via the Online iSpecimen Funding Early Customer Adoption Marketplace 🡡 🡡 2010 – 2011 2012 – 2013 2014 – 2017 2018 – 2025 0 1 140+ 700 Customers Customer…
Slide 23: iSpecimen Marketplace UI/UX
iSpecimen Marketplace UI/UX Click Search to start searching for specimens 23
Slide 24: iSpecimen Marketplace UI/UX
Use search bar to quickly find specimens iSpecimen Marketplace that match search criteria UI/UX 2
Slide 25: iSpecimen Marketplace UI/UX
Refine Search Results Using iSpecimen Marketplace UI/UX Sliders and Check Boxes 25
Slide 26: iSpecimen Marketplace UI/UX
View Quote Request and Add More Specimens iSpecimen Marketplace UI/UX Request a Quote Track and Manage Requests 26
Slide 27: Sources Cited
Sources Cited Page Note Source Cited 4 1 iSpecimen estimates based on In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By Technology (Immunochemistry, Molecular Diagnostics) By End-use, By Region, And Segment Forecasts, 2021 – 2027. Grandview Research, Jan
Slide 28: iSpecimen Marketplace
@ iSPECIMEN Marketplace’